| 查看: 1119 | 回复: 5 | ||
[求助]
求助 USP33中卡维地洛片质量标准
|
如题，客户要求提供USP33中Carvedilol的质量标准复印件（pdf），最好是原料药加片剂的，有资源的朋友支援一下吧，不胜感激！ |
回复此楼» 猜你喜欢
药理学、临床药学方向 调剂
已经有1人回复
-
澳门理工大学人工智能药物发现中心招收2026级博士研究生（申请-考核制）
已经有10人回复
-
药物学论文润色/翻译怎么收费?
已经有271人回复
-
中国医药行业发展现状：标准品推动药品检测水平提升
已经有1人回复
-
标准品的纯度对于药品质量的影响有多大？
已经有0人回复
-
如何制备符合技术要求的药品标准品？
已经有0人回复
-
对照品在药品研发中的不可或缺性
已经有0人回复
-
标准品的分类和用途，你知道多少？
已经有0人回复
-
杂质对照品价格如何界定和正确使用方法
已经有0人回复
-
原研制剂、仿制药：杂质对照品在药品生产中的应用
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
crity328
至尊木虫 (著名写手)
- DRDEPI: 1
- 应助: 160 (高中生)
- 贵宾: 1.292
- 金币: 14059.9
- 散金: 1149
- 红花: 15
- 沙发: 4
- 帖子: 1650
- 在线: 315.9小时
- 虫号: 661953
- 注册: 2008-11-25
- 专业: 药物分析
【答案】应助回帖
★
感谢参与，应助指数 +1
痴夷子皮: 金币+1, 谢谢交流，这个是35版的，呵呵。 2012-09-11 17:04:15
感谢参与，应助指数 +1
痴夷子皮: 金币+1, 谢谢交流，这个是35版的，呵呵。 2012-09-11 17:04:15
|
Carvedilol Tablets DEFINITION Carvedilol Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of carvedilol (C24H26N2O4). IDENTIFICATION • A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. • B. Ultraviolet Absorption 197U Wavelength range: 250–400 nm Cell: 0.2 cm Sample solution: 0.125 mg/mL of carvedilol prepared as follows. Place 10 Tablets in a 150-mL polypropylene tube, and disintegrate the Tablets in methanol (100 mL for the Tablet strengths 3.125, 6.25, and 25 mg, and 50 mL for the Tablet strength 12.5 mg) using a mechanical homogenizer. Transfer the homogenate to an appropriate volumetric flask, and dilute with methanol to volume. Pass through a suitable PTFE filter of 0.45-µm pore size. ASSAY • Procedure Buffer: Dissolve 0.7 g of anhydrous monobasic potassium phosphate in 500 mL of water, and add 10 mL of triethylamine. Adjust with phosphoric acid to a pH of 3.0 ± 0.1. Mobile phase: Dissolve 1.04 g of sodium dodecyl sulfate in 150 mL of Buffer in a 2-L volumetric flask, and sonicate. Add 720 mL of acetonitrile, and dilute with water to volume. Pass through a nylon 66 filter of 0.2-µm pore size. Diluent: Methanol and 1 M hydrochloric acid (9:1) Methanol solution: Methanol and water (1:1) Standard solution: 0.0125 mg/mL of USP Carvedilol RS prepared as follows. Dissolve a quantity of USP Carvedilol RS in a mixture of Diluent and water (9:1), and sonicate until the solution is clear. Dilute with Methanol solution to obtain the required final concentration. Sample stock solution: Transfer a portion of the powdered Tablets (NLT 20), equivalent to 25 mg of carvedilol, to a 100-mL volumetric flask. Add 10 mL of water, shake by hand, then add 70 mL of Diluent, and sonicate for 30 min. Shake on a mechanical shaker for about 30 min, and dilute with Diluent to volume to prepare a 0.25-mg/mL solution. Centrifuge an appropriate amount (about 50 mL) at 2000 rpm for 10 min. Sample solution: 0.0125 mg/mL of carvedilol in Methanol solution from the Sample stock solution. Pass a portion of the solution through a suitable syringe filter of 0.45-µm pore size, discard the first 5 mL, and use the filtrate as the Sample solution. Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 240 nm Column: 4.6-mm × 50-mm; packing L7 Column temperature: 40 Flow rate: 1 mL/min Run time: 30 min Injection size: 25 µL System suitability Sample: Standard solution Suitability requirements Tailing factor: NMT 2.0 Relative standard deviation: NMT 2.0% Analysis Samples: Standard solution and Sample solution Calculate the percentage of the labeled amount of carvedilol (C24H26N2O4) in the portion of Tablets taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) CU = = nominal concentration of the Sample solution (mg/mL) Acceptance criteria: 90.0%–110.0% PERFORMANCE TESTS • Dissolution 711 Test 1 Medium: 0.7% (7 mL/L) of hydrochloric acid, adjusted with 50% (w/w) sodium hydroxide to a pH of 1.45 ± 0.2; 900 mL; deaerated Apparatus 2: 50 rpm Time: 30 min Standard stock solution: Transfer about 7 mg of USP Carvedilol RS to a 250-mL volumetric flask. Add 5 mL of methanol, and sonicate until dissolved. Cool to room temperature, dilute with Medium to volume, and mix well. Standard solution: On the basis of the label claim and using the Standard stock solution, prepare a solution of USP Carvedilol RS in Medium having an appropriate concentration (CS), as shown in Table 1. Table 1 Label Claim (mg) CS (mg/mL) 25 0.028 12.5 0.014 6.25 0.007 3.125 0.0035 Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size. Analytical wavelengths: 285 and 380 nm Path length: 1 cm Blank: Medium Analysis: Calculate the corrected absorbance of the Standard solution and the Sample solution: Acorr = A285 A380 Acorr = = corrected absorbance of the Standard solution or the Sample solution A285 = = absorbance of the Standard solution or the Sample solution at 285 nm A380 = = absorbance of the Standard solution at 380 nm Calculate the percentage of carvedilol dissolved: Result = (AU/AS) × CS × (V/L) × 100 AU = = corrected absorbance from the Sample solution AS = = corrected absorbance from the Standard solution CS = = corrected concentration of the Standard solution (mg/mL) V = = volume of Medium, 900 mL L = = label claim (mg/Tablet) Tolerances: NLT 80% (Q) of the labeled amount of carvedilol (C24H26N2O4) is dissolved. Test 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2. Medium: Simulated gastric fluid without enzymes; 900 mL Apparatus 2, Time, Standard stock solution, Standard solution, Sample solution, and Analysis: Proceed as directed in Test 1. Tolerances: NLT 80% (Q) of the labeled amount of carvedilol (C24H26N2O4) is dissolved. Test 3: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3. Medium: Simulated gastric fluid with pepsin, pH 1.45 (dissolve 12.0 g of sodium chloride and 19.2 g of purified pepsin (porcine origin, activity 800–2500 Units/mg of protein) in 18 mL of hydrochloric acid and sufficient water to make 6 L; adjust with hydrochloric acid to a pH of 1.45); 900 mL Apparatus 2: 50 rpm Time: 30 min Buffer: 2.72 g/L of monobasic potassium phosphate in water. Adjust with phosphoric acid to a pH of 2.0 ± 0.05. Mobile phase: Buffer and acetonitrile (650:350) Standard stock solution: 1.4 mg/mL of USP Carvedilol RS in methanol Standard solution: Dilute the Standard stock solution with Medium to obtain a final concentration of (L/900) mg/mL, where L is the Tablet label claim, in mg. Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size. Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 240 nm Column: 4.6-mm × 15-mm; 5-µm packing L7 Column temperature: 35 Flow rate: 1.5 mL/min Injection size: 20 µL System suitability Sample: Standard solution Suitability requirements Column efficiency: NLT 3500 theoretical plates Tailing factor: NMT 2.0 Relative standard deviation: NMT 2.0% Analysis: Calculate the percentage of carvedilol dissolved: Result = (rU/rS) × (CS/L) × V × 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) L = = label claim (mg/Tablet) V = = volume of Medium, 900 mL Tolerances: NLT 80% (Q) of the labeled amount of carvedilol (C24H26N2O4) is dissolved. • Uniformity of Dosage Units 905 Buffer, Mobile phase, Diluent, Methanol solution, Standard solution, Chromatographic system, and System suitability: Proceed as directed in the Assay. Sample solution: 0.25 mg/mL of carvedilol prepared as follows. Place 1 Tablet into a volumetric flask of appropriate size, based on the label claim. Add water to the flask up to about 10% of volume, and shake by hand to disintegrate the Tablet. Fill the flask up to 75% of volume with Diluent, and sonicate for 30 min to obtain complete disintegration. Shake on a mechanical shaker for 30 min, allow to cool, and dilute with Diluent to volume. Centrifuge an appropriate amount of this solution for 10 min at 2400 rpm, and transfer 4 mL of supernatant into a 100-mL volumetric flask. Fill the flask to about 85% of volume with Methanol solution, and sonicate for 20 min, with intermittent shaking. Dilute with Methanol solution to volume, and pass through a suitable syringe filter of 0.45-µm pore size. Analysis Samples: Standard solution and Sample solution Calculate the percentage of carvedilol (C24H26N2O4) in the Tablet taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) CU = = nominal concentration of the Sample solution (mg/mL) Acceptance criteria: Meet the requirements IMPURITIES • Organic Impurities Buffer, Mobile phase, Diluent, Methanol solution, and Sample stock solution: Prepare as directed in the Assay. Standard stock solution: Use the Standard solution from the Assay. Standard solution: 1.25 µg/mL USP Carvedilol RS in a mixture of Diluent and water (1:1) from the Standard stock solution Sample solution: Dilute with water to volume, 25 mL of the supernatant from the Sample stock solution in a 50-mL volumetric flask. Pass a portion of the solution through a suitable syringe filter of 0.45-µm pore size. Chromatographic system: Proceed as directed in the Assay, except for Injection size. Injection size: 15 µL System suitability Sample: Standard solution Suitability requirements Tailing factor: NMT 2.0 Relative standard deviation: NMT 3.0% Analysis Samples: Standard solution and Sample solution Calculate the percentage of each impurity in the portion of Tablets taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response of each impurity from the Sample solution rS = = peak response of carvedilol from the Standard solution CS = = concentration of USP Carvedilol RS in the Standard solution (mg/mL) CU = = nominal concentration of carvedilol in the Sample solution (mg/mL) Acceptance criteria Individual impurities: NMT 0.2% (specified or unspecified) Total impurities: NMT 1.0% [Note—Disregard any peaks with a relative retention time less than or equal to 0.04 and peaks with less than 0.05% of the nominal carvedilol peak response in the Sample solution. ] ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight, light-resistant containers protected from moisture. Store at controlled room temperature. • Labeling: When more than one Dissolution test is given, the labeling states the test used only if Test 1 is not used. • USP Reference Standards 11 USP Carvedilol RS Auxiliary Information— Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Sujatha Ramakrishna, Ph.D. Senior Scientific Liaison 1-301-816-8349 (SM22010) Monographs - Small Molecules 2 711 Margareth R.C. Marques, Ph.D. Senior Scientific Liaison 1-301-816-8106 (GCDF2010) General Chapters - Dosage Forms Reference Standards RS Technical Services 1-301-816-8129 rstech@usp.org USP35–NF30 Page 2515 Pharmacopeial Forum: Volume No. 34(3) Page 579 |
2楼2012-09-11 17:02:37
3楼2012-09-11 21:49:29
cchang2010
金虫 (正式写手)
- DRDEPI: 1
- 应助: 83 (初中生)
- 金币: 1124.5
- 散金: 19
- 红花: 5
- 帖子: 794
- 在线: 490.5小时
- 虫号: 460706
- 注册: 2007-11-17
- 专业: 色谱分析
【答案】应助回帖
★ ★ ★
曹见敏: 金币+1 2012-09-17 15:32:44
从头开始: 金币+2, 代转金币 2012-09-17 16:00:46
曹见敏: 金币+1 2012-09-17 15:32:44
从头开始: 金币+2, 代转金币 2012-09-17 16:00:46
|
http://g.zhubajie.com/urllink.php?id=12800136cq5zbyo6sgltit2z 原料 http://g.zhubajie.com/urllink.php?id=12800139dpc0q5oqplfqpvg1 片剂 |
4楼2012-09-17 11:24:36
5楼2012-09-17 15:32:14
6楼2012-09-23 00:16:09
